TCF7L2 and colorectal carcinoma: However, the possibility that CRC cells quite often may not be strictly dependent on β-CATENIN or TCF7L2 and that the two factors do not necessarily cooperate in gene regulation call into question the broad suitability of the β-CATENIN/TCF7L2 complex as target for treating colorectal cancer.